With increased regulatory scrutiny, pricing and cost pressures, as well as the rapid developments in genomic technology leading to a more personalised approach to medicine and healthcare, businesses and organisations in the life sciences and healthcare sector face a growing number of complex legal and regulatory challenges in order to stay competitive.
Our focus on business being changed by technology and the digital world enables us to support our clients operating in this rapidly changing environment. Our multidisciplinary team of 270 specialist life sciences and healthcare lawyers worldwide can advise you on every aspect of the business cycle of a life science and healthcare product or service, from incorporation through development to protection and exploitation of intellectual property.
We can advise you on:
If you would like to know more about how we can help your business, please contact Heads of Group: Marc Martens in Brussels and Mark Hilton in London.
An international overview of the regulatory legislation
Helping you navigate the practice and procedure of the Unified Patent Court and Unitary Patent.
Winner of Six Awards:
• EMEA M&A Firm of the Year
• EMEA Patent Litigation Firm of the Year: Medical Devices
• EMEA Venture Capital Firm of the Year
• Netherlands Firm of the Year
• Impact Case of the Year: Fingolimod
• Impact Deal of the Year: Dr Reddy’s Laboratories acquisition of Nimbus Health
Winner of 8 awards:
• Impact Deal of the Year: Envision Pharma acquisition of OKRA.ai
• Impact Case of the Year: Edwards Lifesciences v Meril Life Sciences
• Impact Case of the Year: Abbott Diabetes v Dexcom
• Impact Case of the Year: Xolair Litigations
• Impact Case of the Year: Stelara Litigations
• Impact Case of the Year: Gilead v Nucana
• Impact Case of the Year: Joined cases C-438/21, C-439/21, & C-440/21
• Netherlands Firm of the Year